Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00004338Phase 4Completed
Phase 4, open-label, single-arm trial of zinc acetate in Wilson disease (WD), sponsored by National Center for Research Resources. Primary endpoints: Copper Balance, Clinical Control and 1 more. Started Oct 1993; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00004338.